Literature DB >> 21743030

Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis.

Elizabeth F Redente1, Kristen M Jacobsen, Joshua J Solomon, Abigail R Lara, Sarah Faubel, Rebecca C Keith, Peter M Henson, Gregory P Downey, David W H Riches.   

Abstract

Fibrotic interstitial pneumonias are more prevalent in males of advancing age, although little is known about the underlying mechanisms. To evaluate the contributions of age and sex to the development of pulmonary fibrosis, we intratracheally instilled young (8-12 wk) and aged (52-54 wk) male and female mice with bleomycin and assessed the development and severity of fibrotic lung disease by measurements of lung collagen levels, static compliance, leukocyte infiltration, and stereological quantification of fibrotic areas in histological sections. We also quantified proinflammatory and profibrotic chemokine and cytokine levels in the bronchoalveolar lavage fluid. Aged male mice developed more severe lung disease, indicated by increased mortality, increased collagen deposition, and neutrophilic alveolitis compared with aged female mice or young mice of either sex. Aged male mice also exhibited increased levels of transforming growth factor-β, IL-17A, and CXCL1 in their bronchoalveolar lavage fluid. Young male mice developed a more fibrotic disease after bleomycin instillation compared with female mice, regardless of age. There was no difference in fibrosis between young and aged female mice. Taken together, these findings suggest that the variables of advanced age and male sex contribute to the severity of pulmonary fibrosis in this model. Our findings also emphasize the importance of stratifying experimental groups on the basis of age and sex in experimental and epidemiological studies of this nature.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21743030      PMCID: PMC3191751          DOI: 10.1152/ajplung.00122.2011

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  59 in total

1.  The effects of aging on pulmonary oxidative damage, protein nitration, and extracellular superoxide dismutase down-regulation during systemic inflammation.

Authors:  Marlene E Starr; Junji Ueda; Shoji Yamamoto; B Mark Evers; Hiroshi Saito
Journal:  Free Radic Biol Med       Date:  2010-11-17       Impact factor: 7.376

2.  Bleomycin revisited: towards a more representative model of IPF?

Authors:  Chris J Scotton; Rachel C Chambers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-07-30       Impact factor: 5.464

3.  Gender influences the response to experimental silica-induced lung fibrosis in mice.

Authors:  David M Brass; Sean P McGee; Mary K Dunkel; Sarah M Reilly; Jacob M Tobolewski; Tara Sabo-Attwood; Cheryl L Fattman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-20       Impact factor: 5.464

Review 4.  The aging innate immune system.

Authors:  Christian R Gomez; Eric D Boehmer; Elizabeth J Kovacs
Journal:  Curr Opin Immunol       Date:  2005-10       Impact factor: 7.486

Review 5.  Pulmonary fibrosis: searching for model answers.

Authors:  Felix Chua; Jack Gauldie; Geoffrey J Laurent
Journal:  Am J Respir Cell Mol Biol       Date:  2005-07       Impact factor: 6.914

6.  An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure.

Authors:  Connie C W Hsia; Dallas M Hyde; Matthias Ochs; Ewald R Weibel
Journal:  Am J Respir Crit Care Med       Date:  2010-02-15       Impact factor: 21.405

7.  Aging adversely affects the cigarette smoke-induced glutathione adaptive response in the lung.

Authors:  Neal S Gould; Elysia Min; Steven Gauthier; Hong Wei Chu; Richard Martin; Brian J Day
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

8.  A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes.

Authors:  Tristan J Huie; Amy L Olson; Gregory P Cosgrove; William J Janssen; Abigail R Lara; David A Lynch; Steve D Groshong; Marc Moss; Marvin I Schwarz; Kevin K Brown; Stephen K Frankel
Journal:  Respirology       Date:  2010-06-04       Impact factor: 6.424

9.  An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor β receptor.

Authors:  Rachel K Hoyles; Emma C Derrett-Smith; Korsa Khan; Xu Shiwen; Sarah L Howat; Athol U Wells; David J Abraham; Christopher P Denton
Journal:  Am J Respir Crit Care Med       Date:  2010-08-13       Impact factor: 21.405

10.  Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent.

Authors:  Mark S Wilson; Satish K Madala; Thirumalai R Ramalingam; Bernadette R Gochuico; Ivan O Rosas; Allen W Cheever; Thomas A Wynn
Journal:  J Exp Med       Date:  2010-02-22       Impact factor: 14.307

View more
  67 in total

1.  Essential role for the ATG4B protease and autophagy in bleomycin-induced pulmonary fibrosis.

Authors:  Sandra Cabrera; Mariana Maciel; Iliana Herrera; Teresa Nava; Fabián Vergara; Miguel Gaxiola; Carlos López-Otín; Moisés Selman; Annie Pardo
Journal:  Autophagy       Date:  2015-04-03       Impact factor: 16.016

2.  Protein tyrosine phosphatase α mediates profibrotic signaling in lung fibroblasts through TGF-β responsiveness.

Authors:  Yael Aschner; Anthony P Khalifah; Natalie Briones; Cory Yamashita; Lior Dolgonos; Scott K Young; Megan N Campbell; David W H Riches; Elizabeth F Redente; William J Janssen; Peter M Henson; Jan Sap; Nathalie Vacaresse; Andras Kapus; Christopher A G McCulloch; Rachel L Zemans; Gregory P Downey
Journal:  Am J Pathol       Date:  2014-03-17       Impact factor: 4.307

3.  Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis.

Authors:  Wen-Tan Huang; Hasina Akhter; Chunsun Jiang; Mark MacEwen; Qiang Ding; Veena Antony; Victor John Thannickal; Rui-Ming Liu
Journal:  Exp Gerontol       Date:  2014-11-28       Impact factor: 4.032

4.  Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.

Authors:  Elizabeth F Redente; Rebecca C Keith; William Janssen; Peter M Henson; Luis A Ortiz; Gregory P Downey; Donna L Bratton; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

Review 5.  Sex related differences in the pathogenesis of organ fibrosis.

Authors:  Alejandra Garate-Carrillo; Julisa Gonzalez; Guillermo Ceballos; Israel Ramirez-Sanchez; Francisco Villarreal
Journal:  Transl Res       Date:  2020-03-16       Impact factor: 7.012

6.  Clinical Predictors of Hospital Mortality Differ Between Direct and Indirect ARDS.

Authors:  Liang Luo; Ciara M Shaver; Zhiguo Zhao; Tatsuki Koyama; Carolyn S Calfee; Julie A Bastarache; Lorraine B Ware
Journal:  Chest       Date:  2016-09-20       Impact factor: 9.410

7.  Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.

Authors:  Alison Bamberg; Elizabeth F Redente; Steve D Groshong; Rubin M Tuder; Carlyne D Cool; Rebecca C Keith; Benjamin L Edelman; Bart P Black; Gregory P Cosgrove; Murry W Wynes; Douglas Curran-Everett; Stijn De Langhe; Luis A Ortiz; Andrew Thorburn; David W H Riches
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

8.  Nintedanib reduces pulmonary fibrosis in a model of rheumatoid arthritis-associated interstitial lung disease.

Authors:  Elizabeth F Redente; Martin A Aguilar; Bart P Black; Benjamin L Edelman; Ali N Bahadur; Stephen M Humphries; David A Lynch; Lutz Wollin; David W H Riches
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-03-15       Impact factor: 5.464

9.  Fatty acid nitroalkenes inhibit the inflammatory response to bleomycin-mediated lung injury.

Authors:  Melissa L Wilkinson; Elena Abramova; Changjiang Guo; James G Gow; Alexa Murray; Adolf Koudelka; Veronika Cechova; Bruce A Freeman; Andrew J Gow
Journal:  Toxicol Appl Pharmacol       Date:  2020-09-12       Impact factor: 4.219

Review 10.  Animal models of fibrotic lung disease.

Authors:  Bethany B Moore; William E Lawson; Tim D Oury; Thomas H Sisson; Krishnan Raghavendran; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.